Cargando…

Seizures in Sotos syndrome: Phenotyping in 49 patients

We aimed to describe the phenotypic spectrum of seizures in Sotos syndrome, a genetic condition involving overgrowth, macrocephaly, dysmorphic features, and learning disability, in which 60%‐90% have NSD1 pathogenic variants. Patients were recruited from clinics and referral from support groups. Tho...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortin, Olivier, Vincelette, Christian, Khan, Afsheen Q., Berrahmoune, Saoussen, Dassi, Christelle, Karimi, Mitra, Scheffer, Ingrid E., Lu, Jun, Davis, Kellie, Myers, Kenneth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166795/
https://www.ncbi.nlm.nih.gov/pubmed/34033256
http://dx.doi.org/10.1002/epi4.12484
_version_ 1783701572084039680
author Fortin, Olivier
Vincelette, Christian
Khan, Afsheen Q.
Berrahmoune, Saoussen
Dassi, Christelle
Karimi, Mitra
Scheffer, Ingrid E.
Lu, Jun
Davis, Kellie
Myers, Kenneth A.
author_facet Fortin, Olivier
Vincelette, Christian
Khan, Afsheen Q.
Berrahmoune, Saoussen
Dassi, Christelle
Karimi, Mitra
Scheffer, Ingrid E.
Lu, Jun
Davis, Kellie
Myers, Kenneth A.
author_sort Fortin, Olivier
collection PubMed
description We aimed to describe the phenotypic spectrum of seizures in Sotos syndrome, a genetic condition involving overgrowth, macrocephaly, dysmorphic features, and learning disability, in which 60%‐90% have NSD1 pathogenic variants. Patients were recruited from clinics and referral from support groups. Those with seizures and a clinical diagnosis of Sotos syndrome were included. Phenotyping data were collected via structured clinical interview and chart review. Forty‐nine patients were included. Twenty had NSD1 testing results available; of these, 15 (75%) had NSD1 pathogenic variants. Seizure onset age ranged from 3 months to 12 years. Staring spells (absence or focal impaired awareness seizure) were the most frequently reported semiology (33/49; 67%), followed by febrile seizures (25/49; 51%) and afebrile bilateral tonic‐clonic seizures (25/49; 51%). Most patients (33/49; 67%) had multiple seizure types. The majority (33/49; 67%) had seizures controlled on a single antiseizure medication or no medication. Nine (18%) had drug‐resistant epilepsy. Epilepsy syndromes included febrile seizures plus, Lennox‐Gastaut syndrome, childhood absence epilepsy, and generalized tonic‐clonic seizures alone. The seizure phenotype in Sotos syndrome most commonly involves staring spells, afebrile tonic‐clonic seizures or febrile convulsions; however, other seizure types may occur. Seizures are typically well‐controlled with medication, but drug‐resistant epilepsy occurs in a minority.
format Online
Article
Text
id pubmed-8166795
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81667952021-06-05 Seizures in Sotos syndrome: Phenotyping in 49 patients Fortin, Olivier Vincelette, Christian Khan, Afsheen Q. Berrahmoune, Saoussen Dassi, Christelle Karimi, Mitra Scheffer, Ingrid E. Lu, Jun Davis, Kellie Myers, Kenneth A. Epilepsia Open Short Research Articles We aimed to describe the phenotypic spectrum of seizures in Sotos syndrome, a genetic condition involving overgrowth, macrocephaly, dysmorphic features, and learning disability, in which 60%‐90% have NSD1 pathogenic variants. Patients were recruited from clinics and referral from support groups. Those with seizures and a clinical diagnosis of Sotos syndrome were included. Phenotyping data were collected via structured clinical interview and chart review. Forty‐nine patients were included. Twenty had NSD1 testing results available; of these, 15 (75%) had NSD1 pathogenic variants. Seizure onset age ranged from 3 months to 12 years. Staring spells (absence or focal impaired awareness seizure) were the most frequently reported semiology (33/49; 67%), followed by febrile seizures (25/49; 51%) and afebrile bilateral tonic‐clonic seizures (25/49; 51%). Most patients (33/49; 67%) had multiple seizure types. The majority (33/49; 67%) had seizures controlled on a single antiseizure medication or no medication. Nine (18%) had drug‐resistant epilepsy. Epilepsy syndromes included febrile seizures plus, Lennox‐Gastaut syndrome, childhood absence epilepsy, and generalized tonic‐clonic seizures alone. The seizure phenotype in Sotos syndrome most commonly involves staring spells, afebrile tonic‐clonic seizures or febrile convulsions; however, other seizure types may occur. Seizures are typically well‐controlled with medication, but drug‐resistant epilepsy occurs in a minority. John Wiley and Sons Inc. 2021-04-09 /pmc/articles/PMC8166795/ /pubmed/34033256 http://dx.doi.org/10.1002/epi4.12484 Text en © 2021 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Short Research Articles
Fortin, Olivier
Vincelette, Christian
Khan, Afsheen Q.
Berrahmoune, Saoussen
Dassi, Christelle
Karimi, Mitra
Scheffer, Ingrid E.
Lu, Jun
Davis, Kellie
Myers, Kenneth A.
Seizures in Sotos syndrome: Phenotyping in 49 patients
title Seizures in Sotos syndrome: Phenotyping in 49 patients
title_full Seizures in Sotos syndrome: Phenotyping in 49 patients
title_fullStr Seizures in Sotos syndrome: Phenotyping in 49 patients
title_full_unstemmed Seizures in Sotos syndrome: Phenotyping in 49 patients
title_short Seizures in Sotos syndrome: Phenotyping in 49 patients
title_sort seizures in sotos syndrome: phenotyping in 49 patients
topic Short Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166795/
https://www.ncbi.nlm.nih.gov/pubmed/34033256
http://dx.doi.org/10.1002/epi4.12484
work_keys_str_mv AT fortinolivier seizuresinsotossyndromephenotypingin49patients
AT vincelettechristian seizuresinsotossyndromephenotypingin49patients
AT khanafsheenq seizuresinsotossyndromephenotypingin49patients
AT berrahmounesaoussen seizuresinsotossyndromephenotypingin49patients
AT dassichristelle seizuresinsotossyndromephenotypingin49patients
AT karimimitra seizuresinsotossyndromephenotypingin49patients
AT schefferingride seizuresinsotossyndromephenotypingin49patients
AT lujun seizuresinsotossyndromephenotypingin49patients
AT daviskellie seizuresinsotossyndromephenotypingin49patients
AT myerskennetha seizuresinsotossyndromephenotypingin49patients